Evidence map›Paper›PMID 36293160›Full record

ReviewInternational journal of molecular sciences2022

The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy.

Raffaele Scurati, Nadia Papini, Paola Giussani, Giampietro Alberti, Cristina Tringali

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  10. Effect of physical activity on long COVID fatigue: an unsolved enigma.European journal of translational myology · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Advances in Molecular and Translational Medicine.International journal of molecular sciences · 2023
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Raffaele ScuratiDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milano, Italy.ORCID 0000-0003-3247-1977
Nadia PapiniDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, LITA Segrate, 20090 Segrate, MI, Italy.ORCID 0000-0003-4066-4955
Paola GiussaniDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, LITA Segrate, 20090 Segrate, MI, Italy.ORCID 0000-0002-7793-1757
Giampietro AlbertiDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milano, Italy.
Cristina TringaliDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, LITA Segrate, 20090 Segrate, MI, Italy.ORCID 0000-0002-0632-6197
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long coronavirus disease 19 (COVID-19) is the designation given to a novel syndrome that develops within a few months after infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and that is presenting with increasing incidence because of the numerous cases of infection. Long COVID-19 is characterized by a sequela of clinical symptoms that concern different organs and tissues, from nervous, respiratory, gastrointestinal, and renal systems to skeletal muscle and cardiovascular apparatus. The main common molecular cause for all long COVID-19 facets appears to be related to immune dysregulations, the persistence of inflammatory status, epigenetic modifications, and alterations of neurotrophin release. The prevention and management of long COVID-19 are still inappropriate because many aspects need further clarification. Exercise is known to exert a deep action on molecular dysfunctions elicited by long COVID-19 depending on training intensity, duration, and continuity. Evidence suggests that it could improve the quality of life of long COVID-19 patients. This review explores the main clinical features and the known molecular mechanisms underlying long COVID-19 in the perspective of considering exercise as a co-medication in long COVID-19 management.

Indexed as

COVID-19HumansNerve Growth FactorsQuality of LifeSARS-CoV-2Nerve Growth Factorsexercisehealthinflammationlong COVID-19

Identifiers

PMID36293160
PMCPMC9603679
OpenAlexW4306385344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.